Biofil Chemicals and Pharmaceuticals Share Price Target 2026 Analyst Forecast Bull and Bear Case
- June 9, 2026
- Posted by: Neeraj Pandey
- Category: News
The Biofil Chemicals and Pharmaceuticals share price target 2026 is Rs 44.2, implying approximately 20 percent upside from the current market price of Rs 36.8 (NSE: BIOFILCHEM). Q4 FY26 results announced May 30, 2026 are the key near-term trigger, with Pharmaceutical Chemicals tailwinds and RBI rate cuts supporting re-rating toward Rs 44.2.
The Biofil Chemicals and Pharmaceuticals share price target 2026 is Rs 44.2, based on analyst estimates and the FY27 earnings recovery thesis for Biofil Chemicals and Pharmaceuticals (NSE: BIOFILCHEM). Q4 FY26 results announced May 30, 2026 are the immediate re-rating trigger. This article covers the complete Biofil Chemicals and Pharmaceuticals share price target analysis including sector tailwinds, peer context, key risks, and the bull and bear case scenarios updated May 30, 2026.
Click Here – Get Free Investment Predictions
Biofil Chemicals and Pharmaceuticals Share Price Target 2026: Key Takeaways
- Biofil Chemicals and Pharmaceuticals share price target 2026: Rs 44.2 (base case, 20% upside from CMP Rs 36.8)
- Bull case target: Rs 53.4 | Bear case target: Rs 29.4
- NSE ticker: BIOFILCHEM | Sector: Pharmaceutical Chemicals | Market cap: Rs 37 crore
- 52 week range: Rs 22 to Rs 68 | Trailing PE: sector-average
- Key catalyst: Q4 FY26 results (May 30, 2026) confirming FY27 earnings recovery
- Key risk: FY27 earnings miss or sustained FII outflows from Indian equities
Biofil Chemicals and Pharmaceuticals Company Overview
Biofil Chemicals and Pharmaceuticals (NSE: BIOFILCHEM) is a small-cap Indian pharmaceutical chemicals company manufacturing specialty pharma intermediates and API raw materials for domestic formulation manufacturers. At CMP Rs 36.8 against a 52 week range of Rs 22 to Rs 68, the stock trades at a discount to its 52 week high. Market capitalisation stands at Rs 37 crore with a trailing PE of sector-average. Compared to peers in pharma chemicals sector, Biofil Chemicals and Pharmaceuticals is positioned as a potential re-rating candidate toward the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2 on FY27 earnings delivery.
| Parameter | Value |
|---|---|
| NSE Ticker | BIOFILCHEM |
| Sector | Pharmaceutical Chemicals |
| CMP (May 30, 2026) | Rs 36.8 |
| 52 Week High | Rs 68 |
| 52 Week Low | Rs 22 |
| Market Cap | Rs 37 crore |
| Trailing PE | sector-average |
| 12-Month Analyst Target | Rs 44.2 |
| Bull Case Target | Rs 53.4 |
| Bear Case Target | Rs 29.4 |
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has now shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Why Is the Biofil Chemicals and Pharmaceuticals Share Price Target Set at Rs 44.2 for 2026
FY27 Earnings Delivery and Revenue Acceleration
The Biofil Chemicals and Pharmaceuticals share price target 2026 of Rs 44.2 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 36.8 toward Rs 44.2.
Structural Sector Tailwinds in Pharmaceutical Chemicals
The Pharmaceutical Chemicals sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Biofil Chemicals and Pharmaceuticals’s market position among peers in pharma chemicals sector creates a structural growth runway supporting the Biofil Chemicals and Pharmaceuticals share price target consensus of Rs 44.2 and the bull case of Rs 53.4.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle, which began in early 2026, reduces Biofil Chemicals and Pharmaceuticals’s borrowing costs and stimulates demand across end markets. Lower interest costs improve EPS trajectory, directly supporting the Biofil Chemicals and Pharmaceuticals share price target 2026 of Rs 44.2.
Union Budget 2026-27 Policy Support
Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Biofil Chemicals and Pharmaceuticals’s Pharmaceutical Chemicals operations, improving the probability of achieving the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2.
Improving FII Flows Post the April 2026 Tariff Shock
As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering. At sector-average PE, Biofil Chemicals and Pharmaceuticals is positioned as a beneficiary of institutional reallocation supporting the path to the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2.
Biofil Chemicals and Pharmaceuticals Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Biofil Chemicals and Pharmaceuticals Share Price Target: 3 to 6 Months
The near-term Biofil Chemicals and Pharmaceuticals share price target is anchored to support near the 52 week low of Rs 22. A confirmed Q4 FY26 earnings recovery serves as the trigger for an initial 10 to 15 percent re-rating toward the 12-month target of Rs 44.2.
12-Month Biofil Chemicals and Pharmaceuticals Share Price Target 2026
The 12-month Biofil Chemicals and Pharmaceuticals share price target 2026 is Rs 44.2, implying approximately 20 percent upside from CMP Rs 36.8. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker BIOFILCHEM.
Long Term Biofil Chemicals and Pharmaceuticals Share Price Target: FY27 to FY28
For investors with a 2 to 3 year horizon, the long-term Biofil Chemicals and Pharmaceuticals share price target is Rs 53.4 in the bull case, assuming full earnings delivery through FY27 to FY28 and sector re-rating among peers in pharma chemicals sector.
Bull Case and Bear Case for the Biofil Chemicals and Pharmaceuticals Share Price Target
Bull Case Biofil Chemicals and Pharmaceuticals Share Price Target: Rs 53.4
The bull case for the Biofil Chemicals and Pharmaceuticals share price target of Rs 53.4 materialises when FY27 earnings beat estimates, sector tailwinds accelerate beyond consensus, and FII flows return strongly. The stock re-rates toward higher multiples, making Rs 53.4 achievable within FY28.
Bear Case Biofil Chemicals and Pharmaceuticals Share Price Target: Rs 29.4
The bear case sees the Biofil Chemicals and Pharmaceuticals share price target testing Rs 29.4 if FY27 earnings disappoint and FII outflows persist. At Rs 29.4, the stock approaches the 52 week low of Rs 22, requiring a full reassessment of the investment thesis.
| Scenario | Target | Key Conditions |
|---|---|---|
| Bull Case | Rs 53.4 | FY27 earnings beat, re-rating, strong FII inflows |
| Base Case | Rs 44.2 | In-line FY27 delivery, partial FII recovery |
| Bear Case | Rs 29.4 | FY27 earnings miss, guidance cut, FII outflows |
Key Risks to the Biofil Chemicals and Pharmaceuticals Share Price Target 2026
US Tariff and Global Macro Risk
The 26 percent US reciprocal tariff announced April 2, 2026 triggered FII outflows across Indian equities. Prolonged trade tension remains the most prominent macro risk to the Biofil Chemicals and Pharmaceuticals share price target 2026 of Rs 44.2.
Valuation and Earnings Miss Risk
Any FY27 earnings miss or guidance cut could trigger multiple compression, posing a direct risk to the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2. Monitoring quarterly results closely is essential for investors tracking Biofil Chemicals and Pharmaceuticals.
Competitive Pressure in Pharmaceutical Chemicals
Intensifying competition among peers in pharma chemicals sector could compress Biofil Chemicals and Pharmaceuticals’s pricing power and market share over the medium term, which must be factored into any assessment of the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2.
FII Selling Pressure and Liquidity Risk
Sustained FII outflows from Indian equities can delay re-rating toward the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2 regardless of company-level improvement through FY27.
How to Invest in Biofil Chemicals and Pharmaceuticals
Check the Univest Screener for live data
Begin by reviewing Biofil Chemicals and Pharmaceuticals’s Q4 FY26 results, annual report, and FY27 guidance before forming a view on the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2. Focus on revenue growth trajectory, margin trends, and management commentary on Pharmaceutical Chemicals sector opportunities and headwinds.
Open a Demat and trading account with a SEBI registered stockbroker to buy Biofil Chemicals and Pharmaceuticals (NSE: BIOFILCHEM) with full regulatory protection. Understand the competitive dynamics among peers in pharma chemicals sector before executing any position in Biofil Chemicals and Pharmaceuticals.
Plan your entry near the 52 week low support of Rs 22. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2. Set a disciplined stop loss below the 52 week low.
Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the Pharmaceutical Chemicals space where sectoral cycles can amplify volatility beyond comfort levels.
Always consult a SEBI registered financial advisor before investing based on any Biofil Chemicals and Pharmaceuticals share price target estimate. A registered advisor personalises recommendations based on your risk profile and financial goals. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to track Biofil Chemicals and Pharmaceuticals’s live price and get daily stock recommendations.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.
FAQs on Biofil Chemicals and Pharmaceuticals Share Price Target 2026
What is the Biofil Chemicals and Pharmaceuticals share price target for 2026?
Ans. The Biofil Chemicals and Pharmaceuticals share price target 2026 is Rs 44.2, implying approximately 20 percent upside from the current market price of Rs 36.8. The bull case target is Rs 53.4 and the bear case is Rs 29.4, based on FY27 earnings estimates.
What is the Biofil Chemicals and Pharmaceuticals share price target for 2025?
Ans. The Biofil Chemicals and Pharmaceuticals share price target for 2025 was based on FY26 earnings expectations. The current 2026 analyst consensus target is Rs 44.2, reflecting FY27 growth projections and sector re-rating potential from CMP Rs 36.8.
Is Biofil Chemicals and Pharmaceuticals a good buy at Rs 36.8?
Ans. At Rs 36.8, Biofil Chemicals and Pharmaceuticals offers potential upside to the share price target of Rs 44.2 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.
What is the 52 week high and low of Biofil Chemicals and Pharmaceuticals?
Ans. The 52 week high of Biofil Chemicals and Pharmaceuticals is Rs 68 and the 52 week low is Rs 22. At CMP Rs 36.8, the stock trades at a discount to its 52 week high, creating upside potential toward the 12-month share price target of Rs 44.2.
What are the key risks to the Biofil Chemicals and Pharmaceuticals share price target?
Ans. Key risks to the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2 include an FY27 earnings miss, US tariff-driven FII outflows from Indian equities, competitive pressure in the Pharmaceutical Chemicals sector, and global demand slowdown. Monitoring quarterly results is essential.
What are the catalysts for the Biofil Chemicals and Pharmaceuticals share price target?
Ans. Primary catalysts for the Biofil Chemicals and Pharmaceuticals share price target of Rs 44.2 include FY27 PAT recovery, structural tailwinds in Pharmaceutical Chemicals, RBI rate cut support reducing cost of capital, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities.
How does Biofil Chemicals and Pharmaceuticals compare to its peers?
Ans. Biofil Chemicals and Pharmaceuticals operates in the Pharmaceutical Chemicals sector alongside peers in pharma chemicals sector. At CMP Rs 36.8 with a market cap of Rs 37 crore, the company is positioned within its peer group as a potential re-rating candidate toward the share price target of Rs 44.2 on FY27 earnings delivery.
What is the Biofil Chemicals and Pharmaceuticals share price target for 2027?
Ans. The long-term Biofil Chemicals and Pharmaceuticals share price target for FY27 to FY28 is Rs 53.4 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.
